Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Minoxidil treatment increased hair density in a young Asian girl with short anagen syndrome, but didn't improve hair length or thickness.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Some children are born with unusually short, fine hair because their hair growth phase is short, but this often gets better by itself during puberty.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Higher cannabis use may be linked to more severe hair loss.

FAGA shows varied hair thickness, while TE has more empty follicles.

Polygonum multiflorum extract helps hair grow longer and fights the effects of hormones that cause hair loss.

Cosmetic foam product reduces hair loss and increases hair density in men.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

High TNF-α levels may increase hair loss risk after PRP therapy.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

Minoxidil helps hair growth by activating the β-catenin pathway.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Hes1 protein is important for hair growth and regeneration, and could be a potential treatment for hair loss.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Melatonin helps hair growth in women with hair loss.

EPR spectroscopy showed that spontaneous hair growth results in thicker skin and less pigmented hair than depilation-induced growth.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Loose anagen hair syndrome, often affecting young girls, can be diagnosed with a hair-pull test and usually gets better on its own, but severe cases may need treatment.

Trichobiolight effectively treats hair loss with 82.5% success.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.